Fingerprint
Dive into the research topics of 'Prognostic models to predict survival in non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin with or without bevacizumab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically